Latest Buy Back Programs News

Central Petroleum reported a slight dip in sales volumes and revenue for the September quarter, offset by a significant reserves upgrade and a new long-term gas supply agreement that promises cash flow stability.

Mach7 Technologies reports a modest rise in recurring revenue alongside a comprehensive commercial transformation, positioning itself for growth in AI-driven medical imaging.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.

Articore Group has initiated an on-market share buy-back of up to 10% of its issued capital, signaling renewed confidence in its turnaround and long-term growth prospects.

Brookside Energy reported solid production growth and financial gains in Q3 2025, driven by the Bruins well's full-quarter output and a strategic new area of interest in the Anadarko Basin. The company also initiated a share buy-back and advanced plans for a US listing.

Tribune Resources reported steady gold output from its East Kundana Joint Venture and promising exploration results in Ghana, alongside a stronger cash position for the September quarter.

Metals X reported a 16.6% decline in tin production at its Renison operation for Q3 2025 due to equipment and processing challenges, while cash reserves rose to $279.5 million. The company continues advancing its Rentails project and maintains strategic investments.

Carlton Investments reported a slight rise in net profit and an 8.7% increase in dividends for FY2025, while its investment portfolio grew nearly 60% over five years despite recent market fluctuations.

OFX Group reports solid progress in migrating corporate clients to its new platform, OFX 2.0, despite a decline in net operating income driven by macroeconomic uncertainty. The fintech’s strategic product launches and client growth signal potential for recovery.

Salter Brothers Emerging Companies Limited has announced a further 12-month extension of its on-market share buy-back program, allowing the company to repurchase up to 8.45 million shares to maintain capital management flexibility and enhance shareholder value.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Zip Co Limited has increased its on-market share buy-back limit from $50 million to $100 million, reflecting confidence in its financial strength and growth prospects. The move underscores the company’s commitment to capital management and shareholder returns.